Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Preoxygenation Optimisation in Obese Patients

NCT: NCT03106441 · COMPLETED

NCT IDNCT03106441
StatusCOMPLETED
Start Date2017-06-21
Completion2018-04-12
SponsorNantes University Hospital (OTHER)
First posted
Last updated

Brief Summary

Oro-tracheal intubation in operating room in obese patients with BMI \> 35kg/m2 remains a critical event. The aim of this study is to determine whether Nasal High Flow Therapy by nasal cannula Optiflow® is more efficient than the BIPAP preoxygenation before orotracheal intubation after crash induction in obese patients

Frequently Asked Questions

What is Preoxygenation Optimisation in Obese Patients?

Preoxygenation Optimisation in Obese Patients is a clinical trial registered under NCT03106441. Current status: COMPLETED.

What is the status of NCT03106441?

The current status of NCT03106441 (Preoxygenation Optimisation in Obese Patients) is: COMPLETED.

When did Preoxygenation Optimisation in Obese Patients start?

Preoxygenation Optimisation in Obese Patients started on 2017-06-21.

Related Devices

K201723F&P Optiflow Nasal Oxygen Cannula with CO2 SamplingFisher & Paykel Healthcare, Ltd. K151506Demand Nasal Oxygen Cannula, Modified Demand Nasal Oxygen CannulaSalter Labs K191818F&P Optiflow 3S Nasal Cannula (Small, Medium, Large)Fisher & Paykel Healthcare, Ltd. K222197F&P Optiflow Junior 2/2+ Nasal Cannula Interface RangeFisher & Paykel Healthcare, Ltd. K231956F&P Optiflow+ Duet Nasal CannulaFisher & Paykel Healthcare, Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑